Two transcriptional programs appear to be driving neoplastic progression in IPMN: inflammatory signaling (TNF-NFκB) and cell proliferation (S and G2-M phases). Here, NFKB1 is linked to pancreatic intraductal papillary-mucinous neoplasm.